Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid

被引:72
|
作者
Pelegri, Carme [1 ]
Duran-Vilaregut, Joaquim [1 ]
del Valle, Jaume [1 ]
Crespo-Biel, Natalia [2 ]
Ferrer, Isidre [3 ]
Pallas, Merce [2 ]
Camins, Antoni [2 ]
Vilaplana, Jordi [1 ]
机构
[1] Univ Barcelona, Dept Fisiol, Fac Farm, E-08028 Barcelona, Spain
[2] Univ Barcelona, Unitat Farmacol & Farmacogoniosia, Fac Farm, Inst Biomed, E-08028 Barcelona, Spain
[3] Univ Barcelona, Inst Neuropatol, IDIBELL, Hosp Univ Bellvitge,Hosp Llobregat, E-08007 Barcelona, Spain
关键词
Huntington's disease; Apoptosis; Cell cycle; Striatum;
D O I
10.1016/j.ijdevneu.2008.07.016
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study was undertaken to investigate the potential role of cell cycle re-entry in an experimental model of Huntington's disease and in human brain samples. We found that after treatment of rats with the mitochondrial neurotoxin 3-nitropropionic acid, the expression of cell cycle markers of G I phase measured by immunohistochemistry was induced in the striatal brain region. Furthermore, we detected an increase in the nuclear and also cytoplasmatic E2F-1 expression, suggesting that this protein could activate the apoptotic cascade in rat brain. Western blot analysis of post-mortem brain samples from patients also showed an increase in the expression of E2F-1 and cyclin D1 in comparison with control samples. These results indicate that cell cycle re-entry is activated in Huntington's disease and may contribute to the neurodegenerative process. (C) 2008 ISDN. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 50 条
  • [21] Rhes Deletion Is Neuroprotective in the 3-Nitropropionic Acid Model of Huntington's Disease
    Mealer, Robert G.
    Subramaniam, Srinivasa
    Snyder, Solomon H.
    JOURNAL OF NEUROSCIENCE, 2013, 33 (09): : 4206 - 4210
  • [22] Melanocortin 4 receptor activation protects striatal neurons and glial cells from 3-nitropropionic acid toxicity
    Saba, Julieta
    Carniglia, Lila
    Ramirez, Delia
    Turati, Juan
    Imsen, Mercedes
    Durand, Daniela
    Lasaga, Mercedes
    Caruso, Carla
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 94 : 41 - 51
  • [23] Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity
    Leventhal, L
    Sortwell, CE
    Hanbury, R
    Collier, TJ
    Kordower, JH
    Palfi, S
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 425 (04) : 471 - 478
  • [24] Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease
    Kodsi, MH
    Swerdlow, NR
    NEUROSCIENCE LETTERS, 1997, 231 (02) : 103 - 107
  • [25] Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease
    Sharma, Priya
    Kumar, Manish
    Bansal, Nitin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (09) : 1917 - 1928
  • [26] Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease
    Bogdanov, MB
    Ferrante, RJ
    Kuemmerle, S
    Klivenyi, P
    Beal, MF
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (06) : 2642 - 2644
  • [27] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington's Disease
    Tsang, T. M.
    Haselden, J. N.
    Holmes, E.
    NEUROCHEMICAL RESEARCH, 2009, 34 (07) : 1261 - 1271
  • [28] Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease
    Dalbem, A
    Silveira, CV
    Pedroso, MF
    Breda, RV
    Baes, CV
    Bartmann, AP
    da Costa, JC
    BRAIN RESEARCH, 2005, 1047 (02) : 148 - 158
  • [29] Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity
    Hickey, MA
    Morton, AJ
    JOURNAL OF NEUROCHEMISTRY, 2000, 75 (05) : 2163 - 2171
  • [30] Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease
    Marti, M
    Mela, F
    Ulazzi, L
    Hanau, S
    Stocchi, S
    Paganini, F
    Beani, L
    Bianchi, C
    Morari, M
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (04) : 759 - 767